A recent article from BusinessWire.com predicts how the introduction of new devices, as well as the recession, will have an effect on the body contouring market over the next few years. There have been numerous devices approved since 2008 in the way of laser-assisted liposuction(LAL) and cryolipolysis that have recently become more available to consumers.
Despite the rising frequency of body contouring devices, the price of treatment may deter patients during the recession. Doctors have to earn back their investment on said devices, which cost upwards of $100,000, and do so through the cost of the treatment to patients. The cosmetic surgery industry is currently facing many obstacles; however, as patients postpone or even forego these elective procedures in order to conserve funds.
Despite the decline in device sales from 2008 to 2009, Millennium Research Group predicts an economic revival of the body contouring market to be reported for 2010.
SmartLipo MPX, the first dual-wavelength LAL device available in the market, was launched in Canada and the U.S. in 2008. Other big launches to take place in 2009 included CoolLipo by CoolTouch, SlimLipo by Palomar Medical Technologies, Syneron’s LipoLite, Sciton’s ProLipo PLUS and SmoothLipo by Elem Medical.
The first transdermal ultrasound device to be available in Canada was UltraShape’s Contour 1. In 2009, Medicis’ LipoSonix, which has had difficulty getting FDA approval, received Health Canada approval. To date, there are no transdermal ultrasound devices available in the U.S. In the way of cryolipolysis, Coolsculpting by Zeltiq has been available for off-label fat removal since last summer.
Even with the threats of the recession affecting the body contouring market, the obesity problem in North America guarantees a growing number of prospective patients available. Furthermore, as body contouring technology advances there will be a growing consumer demand and market growth.
No comments:
Post a Comment